SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 196.54-0.2%2:43 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (9591)10/20/1997 11:30:00 AM
From: Scusami   of 32384
 
Andy:

They're giving away the obesity and diabetes part of the business for double digit royalties (I believe).

Henry: What was the potential market for Targretin in the diabetes arena? Do I remember $1B per year of sales? If LGND gets 10 -15% royalty that would be $100M - $150M per year in income. Far short of the $1B in sales. However, another way to look at it is how much would they have netted to the bottom line for that $1B in sales. Perhaps Robinson believes its about what he'll get in royalties from LLY, hence a wash. Also, there's no need to spend $$$ to setup a production facility.

Scusami
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext